register

News & Trends - Pharmaceuticals

Cutting red tape in WA for medicinal cannabis access

Health Industry Hub | November 19, 2019 |

WA Health Minister Roger Cook announced that GPs will now be able to prescribe medicinal cannabis via TGA special access approval and that specialist prescriptions are no longer required for the majority of people seeking medicinal cannabis.

The change brings Western Australia closer into line with other Australian jurisdictions including New South Wales, Queensland and Victoria,
which do not currently require specialist support medicinal cannabis approvals from the TGA.

“Whilst the listing of medicines on the Pharmaceutical Benefits Scheme is the responsibility of the Federal Government, it is important for the Commonwealth to have a flexible system that expedites affordable access to new and emerging healthcare treatments.” said WA Health Minister Roger Cook.

Dr Sanjay Nijhawan, medical director at Cannabis Access Clinics, an SCH company commented “This is a step in the right direction for patients in Western Australia, many of whom could benefit from medicinal cannabis based treatments under the guidelines released by the TGA”.

You may also like Where credibility and trust go, clinicians follow. Download whitepaper.

Andrew Glover, General Manager at Cannabis Access Clinics added “We congratulate Minister Cook for taking steps towards a more streamlined approach for medicinal cannabis access. We expect costs and timelines to come down as a result and more patients in WA will be able try this treatment option as a result”.

Cannabis Access Clinics, which offers bulk billing consults for eligible patients in WA expects patient numbers  to rise significantly with this announcement.

From November 2016 until August 2019 there were 876 approvals to prescribe medicinal cannabis in Western Australia.

Medicinal cannabis products are not approved for use by the Therapeutic Goods Administration or funded by the federally controlled Pharmaceutical Benefit Scheme. They remain classified as controlled drugs throughout Australia.

Register FREE to receive the latest news and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


Medical and Science

NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders

NACCHO-Pfizer partnership ignites global journey for First Nations pharmacy leaders

Health Industry Hub | September 6, 2024 |

Medical & Science: NACCHO has announced the recipients of the 2024 Aboriginal and Torres Strait Islander Pharmacy Leadership Grant: Jes […]

More


ESG

First report exposes glaring gaps in healthcare sector sustainability

First report exposes glaring gaps in healthcare sector sustainability

Health Industry Hub | September 6, 2024 |

ESG: The first comprehensive report outlining sustainability and decarbonisation efforts in the Australian healthcare sector has been released, aimed at […]

More


News & Trends - Pharmaceuticals

Expanded access to Shingrix is a start: 'We need reform for all current and future vaccines'

Expanded access to Shingrix is a start: ‘We need reform for all current and future vaccines’

Health Industry Hub | September 6, 2024 |

Pharma News: Access to GSK’s Shingrix vaccine, following the 2023-24 federal budget decision, has been limited to “immunocompromised patients aged […]

More


News & Trends - Pharmaceuticals

NSW government fails to back mental health inquiry findings with essential funding

NSW government fails to back mental health inquiry findings with essential funding

Health Industry Hub | September 6, 2024 |

NSW Government has support for 24 of 39 recommendations from the Portfolio Committee’s Inquiry Report on ‘Equity, accessibility and appropriate […]

More


This content is copyright protected. Please subscribe to gain access.